# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...
HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Asensus Surgical (AMEX:ASXC) from Buy to Neutral and lower...
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical (AMEX:ASXC) with a Buy and maintains $2 pr...
Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08...